US 10813952
NK cells with an increased antibody-dependent cellular toxicity (ADCC) against tumors
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 10813952 (NK cells with an increased antibody-dependent cellular toxicity (ADCC) against tumors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K2039/57, A61K2039/572